Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07177105
Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC (SURGAN-ICI)
Primary Tumor Resection Combined With Sintilimab and Chemotherapy for Advanced Non-small-cell Lung Cancer: A Randomized Controlled Trial
Sponsor: Jianxing He
Conditions
Non Small Cell Lung Cancer
Interventions
Cytoreductive surgery Immunochemotherapy
Updated 1 time since 2025 Last updated: Sep 12, 2025 Started: Sep 10, 2025 Primary completion: Oct 1, 2028 Completion: Oct 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Non Small Cell Lung Cancer, this trial is actively recruiting participants. The trial is conducted by Jianxing He and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jianxing He
Data source: The First Affiliated Hospital of Guangzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.